Organon & Co. is a global healthcare company that specializes in the research, development, and commercialization of prescription medicines, primarily focusing on women''s health and biosimilars. The company was established in 2021 as a spin-off from Merck & Co., Inc. (known as MSD outside of the United States and Canada). Organon is headquartered in Jersey City, New Jersey, United States.